401 related articles for article (PubMed ID: 18791337)
1. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
[TBL] [Abstract][Full Text] [Related]
2. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
3. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
[TBL] [Abstract][Full Text] [Related]
4. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
5. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection.
Burkhard FC; Bader P; Schneider E; Markwalder R; Studer UE
Eur Urol; 2002 Aug; 42(2):84-90; discussion 90-2. PubMed ID: 12160577
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH
AJR Am J Roentgenol; 2015 Sep; 205(3):W328-34. PubMed ID: 26295669
[TBL] [Abstract][Full Text] [Related]
7. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
[TBL] [Abstract][Full Text] [Related]
8. Open pelvic lymph node dissection for prostate cancer: a reassessment.
Campbell SC; Klein EA; Levin HS; Piedmonte MR
Urology; 1995 Sep; 46(3):352-5. PubMed ID: 7544933
[TBL] [Abstract][Full Text] [Related]
9. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
10. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of the need for pelvic lymphadenectomy in low grade prostate cancer.
Fournier GR; Narayan P
Br J Urol; 1993 Oct; 72(4):484-8. PubMed ID: 7505192
[TBL] [Abstract][Full Text] [Related]
12. Extended pelvic lymphadenectomy in patients with clinically localised prostate cancer: A prospective observational study.
Ramos JG; Caicedo JI; Cataño JG; Villarraga LG; Trujillo CG; Robledo D; Plata M
Actas Urol Esp; 2016 Sep; 40(7):446-52. PubMed ID: 26995770
[TBL] [Abstract][Full Text] [Related]
13. [Radical perineal prostatectomy without lymphadenectomy. Patients with cT1 + 2, G1 +2, PSA < or = 10 ng/ml prostate carcinoma].
Jakse G; Brehmer B; Wolff JM; Aretz R; Handt S
Urologe A; 1999 Mar; 38(2):143-9. PubMed ID: 10231935
[TBL] [Abstract][Full Text] [Related]
14. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer].
Peneau M; Villers A; Molinié V; Theis D; Soulié M
Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168
[TBL] [Abstract][Full Text] [Related]
15. Indications for pelvic lymphadenectomy in prostate cancer.
Link RE; Morton RA
Urol Clin North Am; 2001 Aug; 28(3):491-8. PubMed ID: 11590808
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node dissection in more than 1200 prostate cancer cases: rate and prediction of lymph node involvement depending on preoperative tumor characteristics.
Winter A; Kneib T; Henke RP; Wawroschek F
Int J Urol; 2014 Jan; 21(1):58-63. PubMed ID: 23659488
[TBL] [Abstract][Full Text] [Related]
17. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.
Kawakami J; Meng MV; Sadetsky N; Latini DM; Duchane J; Carroll PR;
J Urol; 2006 Oct; 176(4 Pt 1):1382-6. PubMed ID: 16952638
[TBL] [Abstract][Full Text] [Related]
18. Limitations of radioguided surgery in high-risk prostate cancer.
Weckermann D; Dorn R; Holl G; Wagner T; Harzmann R
Eur Urol; 2007 Jun; 51(6):1549-56; discussion 1556-8. PubMed ID: 16996201
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
[TBL] [Abstract][Full Text] [Related]
20. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
